在(zai)2024中(zhong)國(guo)創新(xin)器械與(yu)智能制造榜(bang)(bang)TOP100、中(zhong)國(guo)創新(xin)醫(yi)藥與(yu)生物(wu)制品榜(bang)(bang)TOP100、中(zhong)國(guo)醫(yi)療與(yu)健(jian)康(kang)創新(xin)服務(wu)(wu)榜(bang)(bang)TOP100、中(zhong)國(guo)醫(yi)療健(jian)康(kang)產(chan)業(ye)鏈服務(wu)(wu)榜(bang)(bang)TOP100四張(zhang)主榜(bang)(bang)單中(zhong),共計有400家企業(ye)上榜(bang)(bang),總(zong)(zong)估(gu)值(zhi)(zhi)約(yue)(yue)1.26萬億元(yuan)(yuan),總(zong)(zong)平(ping)均估(gu)值(zhi)(zhi)同比回升約(yue)(yue)2.74%。其(qi)中(zhong),有86.75%的上榜(bang)(bang)企業(ye)估(gu)值(zhi)(zhi)集(ji)中(zhong)于10-60億元(yuan)(yuan)區間,構(gou)成(cheng)大(da)健(jian)康(kang)產(chan)業(ye)非上市公(gong)司主要群(qun)體;12家企業(ye)估(gu)值(zhi)(zhi)突破百億;2家企業(ye)估(gu)值(zhi)(zhi)在(zai)200億元(yuan)(yuan)以上;估(gu)值(zhi)(zhi)排名TOP10企業(ye)估(gu)值(zhi)(zhi)均值(zhi)(zhi)達145.2億元(yuan)(yuan)。
地(di)區(qu)分布上(shang),長(chang)三角經(jing)濟區(qu)、粵港澳經(jing)濟區(qu)仍是大(da)健(jian)(jian)康(kang)企(qi)(qi)(qi)業(ye)(ye)的(de)成(cheng)長(chang)沃土;深圳(zhen)、杭州為大(da)健(jian)(jian)康(kang)企(qi)(qi)(qi)業(ye)(ye)駐地(di)第(di)(di)二梯隊(dui);廣(guang)州、蘇州為大(da)健(jian)(jian)康(kang)企(qi)(qi)(qi)業(ye)(ye)駐地(di)第(di)(di)三梯隊(dui);以(yi)成(cheng)都(dou)市為核(he)心的(de)西(xi)部(bu)(bu)經(jing)濟圈大(da)健(jian)(jian)康(kang)產業(ye)(ye)正在快速崛起(qi),成(cheng)為醫療健(jian)(jian)康(kang)企(qi)(qi)(qi)業(ye)(ye)西(xi)部(bu)(bu)聚集高(gao)地(di)。
因文章篇幅有(you)限,以(yi)上僅展示(shi)2024未來醫療(liao)100強的主(zhu)榜(bang)(bang)系列榜(bang)(bang)單(dan),更多(duo)榜(bang)(bang)單(dan)請以(yi)動脈(mo)網(wang)官(guan)方(fang)公布為準(zhun)。